Rothwell Figg Ernst & Manbeck

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases482

Challenger50%

Patent Owner50%

NPE50%

rothwell-figg

rfem.com

Practice Areas

Comp. Arch. and SoftwareBiotechCommunications

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
01/29/25	Regeneron Pharmaceuticals Inc v. Amgen Inc 1:24-CV-00039 ( N.D. WV )	USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025) USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025)
01/29/25	Regeneron Pharmaceuticals Inc v. Amgen Inc 1:24-CV-00039 ( N.D. WV )	OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025) OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025)
12/20/24	Sherwin Williams Co v. PPG Industries Inc 2:17-CV-01023 ( W.D. PA )	REPLY BRIEF re [1133] Motion for Attorney Fees filed by PPG INDUSTRIES INC.. (Fletcher, Andrew) (Entered: 12/20/2024)
10/21/24	HQ Specialty Pharma Corp v. Fresenius Kabi USA LLC 1:21-CV-01714 ( D. DE )	ORAL ORDER re [299] Letter: IT IS HEREBY ORDERED that, by Monday, October 28, 2024, the parties shall file any responses or objections to the request for trial exhibits. If no objections are received, the exhibits will be provided electronically to the requesting party. ORDERED by Judge Maryellen Noreika on 10/21/2024. (mdb) (Entered: 10/21/2024)
10/21/24	HQ Specialty Pharma Corp v. Fresenius Kabi USA LLC 1:21-CV-01714 ( D. DE )	Letter to Judge Noreika from Anne Gaza, Esq. regarding request for trial exhibits - re [264] Exhibit List, [263] Exhibit List. (mdb) (Entered: 10/21/2024)
09/26/24	Unverferth Mfg Co Inc v. Par Kan Co LLC 3:23-CV-00653 ( N.D. IN )	OPINION AND ORDER: The Court hereby DENIES Defendant's Motion for Judgment on the Pleadings [38] . The Court GRANTS IN PART, with regards to Counterclaim 2, and DENIES IN PART, with regard to Counterclaim 1, Plaintiff's Motion for Judgment on the Pleadings [35] . Further, the Court MOOTS Plaintiff's Motion to Dismiss [32] because Defendant filed Amended Counterclaims [42] . Finally, the Court MOOTS Plaintiff's Second Motion for Hearing [71] because of the instant order. Signed by Judge Gretchen S Lund on 9/26/2024. (jss) (Entered: 09/26/2024) OPINION AND ORDER: The Court hereby DENIES Defendant's Motion for Judgment on the Pleadings [38] . The Court GRANTS IN PART, with regards to Counterclaim 2, and DENIES IN PART, with regard to Counterclaim 1, Plaintiff's Motion for Judgment on the Pleadings [35] . Further, the Court MOOTS Plaintiff's Motion to Dismiss [32] because Defendant filed Amended Counterclaims [42] . Finally, the Court MOOTS Plaintiff's Second Motion for Hearing [71] because of the instant order. Signed by Judge Gretchen S Lund on 9/26/2024. (jss) (Entered: 09/26/2024)
09/03/24	Flocast LLC v. Movi Family LLC 6:23-CV-01174 ( N.D. NY )	Report on the Filing and Determination of an Action regarding patent and/or trademark number(s) US D714,072S - Case Closed. (ban) Modified on 9/3/2024 - Copy of report and Consent judgment mailed to US Patent Ofifce (ban). (Entered: 09/03/2024)
09/03/24	Flocast LLC v. Movi Family LLC 6:23-CV-01174 ( N.D. NY )	CONSENT JUDGMENT. Signed by U.S. District Judge Mae A. D'Agostino on 09/03/2024. (ban) (Entered: 09/03/2024)
08/26/24	Vlsi Technology LLC v. Intel Corp 1:19-CV-00977 ( W.D. TX )	Notice of Correction: re [844] Jury Trial Held / Completed. Please disregard this entry as it was entered in error. Thank you. (pg) (Entered: 08/26/2024)
08/16/24	IN RE QUANTUM Technology INNOVATIONS LLC Patent LITIGATION 1:24-CV-01103 ( S.D. NY )	AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 8/16/2024 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (vfr) (Entered: 08/16/2024) AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 8/16/2024 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (vfr) (Entered: 08/16/2024)